Trending stocks today
BMO MSCI USA High Quality ETF
MEG Energy Corp
Athabasca Oil Sands Corp
Arc Resources Ltd
Royalty Pharma plc
Mercury General Corp
SABESP
iShares 20+ Year Treasury Bond ETF
Imperial Oil
CASH
Cleveland-Cliffs Inc.
American Express
CME Group Inc
Expedia
Mastercard Inc.
Netflix Inc.
Global Ship Lease Inc
Equinor ASA
Copa Holdings
Ed Ho
Portfolio Manager at Dynamic Mutual Funds
Member since: Dec '00 · 64 Opinions
Rating
Big Win
Win
Neutral
Loss
Big Loss
Stock Opinions by Ed Ho
WAIT
Have a great noninvasive product to deal with heart problems. Have a new products in the pipeline. Good potential, but may be fully valued.
misc industrial products
TOP PICK
Not really happy with management. Took a big drop and is an interesting buy now. The drug works. Potential of being in phase three next year. Really cheap.
biotechnology
pharmaceutical
TOP PICK
Biotech world has had a tough time in the last month. This company is progressing well. Will take over the clinical development which is very lucrative for the company. Likes management and their pipeline.
biotechnology
pharmaceutical
TOP PICK
Have about $11/12 million in cash and $23/24 million in sales. Profitable. Trading at half X sales. Cheap. Good management.
consulting
TOP PICK
Have put in new (better) management and have recapitalized the costs.
transportation equip & components
TOP PICK
Disappointed on their 2nd quarter, but they were building and shipping inventory in the first two quarters so results won't show until the 3rd/4th quarters.
other services
BUY
Incredibly good management. Expects them to do $.10/$.12 in earnings this year.
other services
WAIT
Has a great product. Had some accounting issues. Expects they will succeed in the long term. Have to start showing sales. A " show me" company.
biotechnology
pharmaceutical
TOP PICK
Has an interesting pipeline of products. An early stage product is a diabetes treatment.
biotechnology
pharmaceutical
DON'T BUY
Management has done a great job in bringing this company back from the dead. Not sure how much they can grow. Probably fairly valued.
computer software
processing
DON'T BUY
An exceptionally well-run company. Relative to the other printers, it is an expensive stock. Good track record deserves a premium, but prefers a pure cyclical play.
publishing
printing
BUY
Have a good technology and a well-run company. The question is, when do they get approval in the US for their commercialization of their ultraviolet scope.
medical services
TOP PICK
Have proven up 2,000,000 tons of rock which, at $300 a ton makes it a low risk exploration play. Cheap.
other mines
TRADE
Have had problems doing commercial production of silk fibers.
biotechnology
pharmaceutical
DON'T BUY
Trying to raise finances to move into the US market which could be risky. Fairly valued.
misc consumer products
Advertising
